INDICATORS OF MARKERS OF BONE METABOLISM IN PATIENTS WITH GENERALIZED PERIODONTITIS DEPENDING ON BLOOD GROUP

Page created by Katie Hernandez
 
CONTINUE READING
Archives of the Balkan Medical Union                                                             vol. 54, no. 1, pp. 72-77
Copyright © 2019 Balkan Medical Union                                                                         March 2019

                                                                                         ORIGINAL PAPER

INDICATORS OF MARKERS OF BONE METABOLISM
IN PATIENTS WITH GENERALIZED PERIODONTITIS
DEPENDING ON BLOOD GROUP
Yurii BANDRIVSKY1 , Orysia BANDRIVSKA2, Romam GNID3, Lidia MINKO3,
Maryana SHEVCHUK3
1
  „I. Horbachevsky“ Ternopil State Medical University, Department of Child Dentistry, Ternopil, Ukraine
2
  „I. Horbachevsky“ Ternopil State Medical University Department of Orthopedic Dentistry, Ternopil,
Ukraine
3
  „Danylo Halytsky“ Lviv National Medical University, Department of Therapeutic Dentistry FPGE, Lviv,
Ukraine
                                     Received 2 Dec 2018, corrections received 3 Jan 2019, Accepted 27 Jan 2019
                                                                              https://doi.org/10.31688/ABMU.2019.54.1.10

ABSTRACT                                                    RÉSUMÉ

Introduction. The close relationship of the osteo-          Indicateurs des marqueurs du métabolisme osseux
porosis with the periodontal tissue disease is of great     chez des patients présentant une périodontite géné-
importance in dentistry, because of the development         ralisée d’après l’appartenance à un groupe sanguin
of inflammatory-destructive processes of tooth hold-
ing tissues. A database to individualize the basics of      Introduction. La stomatologie revêt une grande im-
metabolism in terms of bone remodeling in patients          portance pour ce qui est de la relation entre l’ostéo-
with generalized periodontitis (GP) in connection with      porose et la maladie des tissus parodontaux, considé-
AB0-belonging will reveal the fundamental basis of the      rée comme un facteur de risque du développement
influence of group-specific features of blood flow and      des processus inflammatoires destructeurs des tissus
treatment of generalized periodontitis.                     qui fixent les dents. L’absence d’une base de données
The aim of the study was to assess the dynamics of          permettant d’individualiser le métabolisme primaire
bone remodeling markers in blood and oral liquid of         dans les paramètres de remodelage osseux chez les
patients with generalized periodontitis, with different     patients atteints de parodontite généralisée (GP) en
blood groups.                                               lien avec l’appartenance à AB0, révélera la base fon-
Material and methods. The clinical and laboratory           damentale de l’influence des caractéristiques de la cir-
studies were conducted in 175 patients with general-        culation sanguine et du traitement de la parodontite
ized periodontitis (main group) and in 120 persons          généralisée.
without somatic and dental diseases (comparison             Le but de l’étude était la dynamique des marqueurs
group), who were divided into groups in connection          de remodelage osseux dans le sang et le liquide buccal

      Address for correspondence:       Yurii BANDRIVSKY
                                        Dept. of Child Dentistry, I. Horbachevsky Ternopil State Medical University,
                                        Ternopil, Ukraine
                                        Address: Chekhova 7, Ternopil 46001, Ukraine
                                        Email: bandrivsky.83@gmail.com, phone + 380973047399
Archives of the Balkan Medical Union

with AB0-belonging. It was determined the activity of      des patients atteints de parodontite généralisée avec
acid and alkaline phosphatase in blood and oral liquid     une affiliation différente au groupe sanguin.
of patients, by conventional biochemical methods, and      Méthodes. Les études cliniques et de laboratoire ont
levels of osteocalcin and C-end telopeptide by ELISA.      été menées chez 175 patients atteints de parodontite gé-
Results. Patients with generalized periodontitis pre-      néralisée (groupe principal) et chez 120 personnes sans
sented a significant increase of the markers of bone       maladies somatiques ou dentaires (groupe témoin), di-
resorption (acid phosphatase and C-end telopeptides),      visées en groupes liés à l’appartenance à AB0. L’activité
while healthy persons presented a reduction of these       de la phosphatase acide et alcaline dans le sang et le
parameters of bone formation (osteocalcin and alka-        liquide buccal des patients a été déterminée par des
line phosphatase) in blood and oral liquid, regardless     méthodes biochimiques classiques et par les taux d’os-
of blood group affiliation. Further, processes of bone     téocalcine et de télopeptide C-end par ELISA.
resorption in blood and oral liquid were examined          Les résultats. Il est établi que, chez les patients atteints
in patients with GP, carriers of O(I) and A(II) blood      de parodontite généralisée, on a examiné une augmen-
groups. It was noted that the process of bone forma-       tation significative des valeurs des marqueurs de la
tion for these levels of osteocalcin and alkaline phos-    résorption osseuse (phosphatase acide et télopeptides
phatase were significantly lower in patients with GP, in   C-end) dans le contexte de la réduction de ces para-
O(I) and B(III) blood groups.                              mètres de formation liés aux valeurs chez les personnes
Conclusions. The results of the study showed that in       en bonne santé, quelle que soit leur appartenance à un
patients with GP there is an imbalance in the process-     groupe sanguin. Ainsi, des processus plus importants
es of bone remodeling, regardless of AB0-belonging.        de résorption osseuse dans le sang et le liquide buccal
The study of the composition and functions, not only       ont été examinés chez des patients atteints de GP, de
of blood, but also of saliva, can find high regulatory     porteurs de groupes de sang O (I) et A (II). Ainsi, il est
and trophic potential of this biological environment       à noter que le processus de formation osseuse de ces
and the diversity of its protective and compensatory       taux d’ostéocalcine et de phosphatase alcaline était si-
features.                                                  gnificativement plus faible chez les patients atteints de
                                                           GP, porteurs de groupes de sang O (I) et B(III).
Keywords: generalized periodontitis, AB0-belonging,        Conclusions. Les résultats des études menées ont
bone tissue, markers of bone metabolism.                   montré que les processus de remodelage osseux sont
                                                           déséquilibrés chez les patients atteints de GP, indépen-
Abbreviations                                              damment de leur appartenance à AB0. L’étude de la
GP = generalized periodontitis                             composition et des fonctions du sang, mais aussi de
TRACP = acid phosphatase tartrate                          la salive, permet de mettre en évidence un potentiel
BSALP = alkaline phosphatase                               régulateur et trophique élevé pour cet environnement
P1CP = C-terminal telopeptides                             biologique et la diversité de ses caractéristiques protec-
OC = osteocalcin                                           trices et compensatrices.
                                                           Mots-clés: parodontite généralisée, appartenance
                                                           AB0, tissu osseux, marqueurs du métabolisme osseux.

INTRODUCTION                                               periodontal disease and consider it as a risk factor
                                                           for the occurrence of periodontal disease. Age-related
     One of the main problems of modern dentistry          bone tissue repair, a violation of bone metabolism,
are periodontal tissue diseases, because of their sig-     accelerates the resorption of the alveolar process,
nificant prevalence among people of different ages,        causing the deterioration of the flow of generalized
the lack of pre nosological diagnostic methods and         periodontitis (GP)11-13.
effective methods of prevention and treatment1-4.               At the same time, there is practically no database
Generalized periodontal diseases are characterized         for the individualization of the molecular basis of me-
by the progression of the inflammatory-destructive         tabolism in some parameters, one of which is blood
processes, which with age leads to the complete de-        group genetically determined14. The study of bone
struction of the tooth-holding apparatus and the pre-      remodeling data in patients with generalized peri-
mature loss of teeth 5-8. As a result of impaired bone     odontitis, in connection with AB0-affiliation, would
metabolism of the alveolar process, its resorption is      increase the effectiveness of evaluating the results of
accelerated, which is caused by the action of both lo-     bone metabolism markers, for a new approach, in
cal regulatory and systemic causes3,9,10. Recent stud-     connection with the influence of group-specific blood
ies underlined the relationship of osteoporosis with       on the course of generalized periodontitis15-17.

                                                                                               March 2019       /   73
Indicators of markers of bone metabolism in patients with generalized periodontitis… – BANDRIVSKY et al

     In the literature, there is interest for the compo-   RESULTS
sition and functions not only of the blood, but also
of oral fluid, in order to reveal the high regulatory           We have found that the serum activity of
and trophic potential of this biological environment       TRACP-lysosomal enzyme, which hydrolyzes phos-
and the diversity of its protective and compensatory       phoric monoesters in an acidic environment11,25, in
properties18-20.                                           practically healthy individuals of the control group,
                                                           was on average 36.68% lower than in patients with
                                                           generalized periodontitis (3.19±0.09 ng/mL versus
THE OBJECTIVE OF THE STUDY was to evaluate the dy-
                                                           4.36±0.09 ng/mL, respectively, p
Archives of the Balkan Medical Union

                     Figure 1. Dynamics of bone metabolism markers depending on blood group.

GP was: by 29.02%, p
Indicators of markers of bone metabolism in patients with generalized periodontitis… – BANDRIVSKY et al

                               Figure 2. Dynamics of markers of bone metabolism in the oral fluid
                                   in patients of study groups depending on the blood group.

CONCLUSIONS                                                             8. Shiau HJ, Reynolds MA. Sex differences in destructive
                                                                            periodontal disease: a systematic review. J Periodontol.
     The analysis of the values of bone remodeling                          2010;81(10):1379–1389.
                                                                        9. Mazur IP, Povoroznyuk VV. Kostnaya sistema I zabolevani-
markers in patients with GP found a significant im-                         ya parodonta. Sovremennaya stomatologiya. 2000;(2):32-36 [in
balance in the processes of formation and resorption                        Ukrainian].
of bone tissue compared with the data in practically                    10. Stahl SS. Host resistance and periodontal diseases. J Dent
healthy individuals, regardless of the blood group.                         Res. 2010;49(2):248–255.
                                                                        11. Sones FD, Walinsby JE. Osteoporosis and mandibular bone
                                                                            resorption a prosthodontic perspective. J Prosthet Dent.
                                                                            2016;6:732-736.
Compliance with Ethics Requirements:                                    12. Tomaszewski T. Assessment of mandible bone structure
      „The authors declare no conflict of interest regarding                in patients with generic osteoporosis symptoms. Annales
this article“                                                               Universitatis Mariae Curie-Sklodowska. 2012;57: 329-341.
      „The authors declare that all the procedures and ex-              13. Fourel J. Periodontosis: a periodontal syndrome. J
                                                                            Periodontol. 1972;43:240-255.
periments of this study respect the ethical standards in the            14. Haffajee AD, Socransky SS. Microbial etiological agents
Helsinki Declaration of 1975, as revised in 2008(5), as                     of destructive periodontal diseases. Periodontology. 1994;
well as the national law.“                                                  5:78-111.
                                                                        15. Bennet E, Steffensen R, Clausen H, et al. Genomic cloning
                                                                            of the human histo-blood group ABO locus. Biochem Biophys
                                                                            Res Commun. 1995; 206:318-325.
REFERENCES                                                              16. Jee WS. Principles in bone physiology. J Musculoskelet
                                                                            Neuronal Interact 2000; 1:11-13.
1. Abolmasov NN. Strategiya i taktika zabolevaniy parodonta.            17. Isacov I, Levco S. Preoperative assessment of patients with
   Stomatologiya. 2003;(4): 34-39. [in Russian].                            inflammatory processes in the maxillo-facial region: a mini-
2. Grigorian AS, Grudyanov AI, Ryabukhina NA, Frolova                       review. Arch Balk Med Union. 2018;53(2): 275-280.
   OA. Bolezni parodonta. Patogenez, dIagnostika, lecheniye.            18. Nomura Y, Tanaki Y, Tanaka T. Screening of periodontitis
   Moscow: MIA. 2004: 287.                                                  with salivary enzyme test. J Oral Sral Sci. 2006; 12:177–183.
3. Bandrivsky YL, Vynogradova OM, Minko LY Modern as-                   19. Schenkel-Bruner H. Human blood groups. Chemical and
   pects of etiopathogenesis of periodontal disease. European               biochemical basis of antigen specificity. New York, 2000,
   International Journal of Science and Technology. 2017; (1): 44-50.       30-293.
4. Petersen P. E. The global burden of oral diseases and risk to        20. Young MF. Bone matrix proteins: further function, regula-
   oral health. Bull. World Health Organ. 2015;83(9):661-669.               tion, and relationship to osteoporosis. Osteoporosis Int. 2003;
5. Bandrivska NN, Bandrivsky YL. Clinical morphology symp-                  14: S35-S42.
   tomatics of inflammatory parodontal diseases. Ukrainskyi             21. Yamamoto, F. Molecular genetic of the ABO histo-blood
   medychnyi almanakh. 2009;(5):19-21 [in Ukrainian].                       group system. Vox Sang. 1995;69:1-7.
6. Borysenko AV. Therapeutic stomatology. Kyiv, Medytsyna,              22. Neil DA, Reid ME. The Rh blood group system: a review.
   2008; 2:409.                                                             Blood. 2000;15:375-387.
7. Offenbacher S. Periodontal diseases pathogenesis. Amer               23. Mitchell B, Cole S, Bauer R, et al. Genes influencing vari-
   Periodontol. 2013;1: 821-878.                                            ation in serum osteocalcin concentrations are linked to

76    /   vol. 54, no. 1
Archives of the Balkan Medical Union

    markers on chromosomes 16q and 20ql. The Journal of           26. Chen DZM, Mundy GR. Bone morphogenetic proteins.
    Clinical Endocrinology & Metabolism. 2002; 85(4):1362-1366.       Growth Fact. 2014;22:233–241.
24. Daniels GL, Anstee DJ, Carton JP, et al. Blood groups clas-   27. Duncan E, Cardon L, Sinsheimer J, et al. Site and gender
    sification. Vox Sang. 1995; 69(4): 265-279.                       specificity of inheritance of bone mineral density. J Bone
25. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone          Miner Res. 2003;18(8):1531.
    remodeling. Emerging insights into the pathophysiology of     28. Schaffer M. Teeth in the line of mandibular fractures : epide-
    osteoporosis. N Engl J Med. 1995;332(5):305-311.                  miology, management and complications. Revista de Cirurgia
                                                                      e Traumatologia Bucco-maxillo-facial. 2013;13(2): 23–30.

                                                                                                          March 2019        /   77
You can also read